Spondylarthropathies (SpA) are among the most common chronic inflammatory rheumatisms in adults, responsible for a muscular loss or sarcopenia which can be very disabling, not much documented in the literature, and not yet studied in France. In addition, sarcopenia is associated with decreased physical activity and increased risk of falls and fractures. A better characterization of the determinants of this muscular loss will allow to better detect and take care of it. The aim is to conduct the first French study on the prevalence and severity of sarcopenia in patients with spondyloarthropathies and to study the variables that may be associated with it. Finally, we propose to evaluate obesity related to sarcopenia in these patients and compare them to cases matched for age and sex (from OFELY / STRAMBO cohorts, Lyon, FRANCE). This is a prospective interventional and monocentric study with minimal risks and constraints: patients will be included for one day for an evaluation of their sarcopenia by measuring their muscle strength, physical performance and body composition and recording of their socio-demographic and disease characteristics.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SCREENING
Masking
NONE
Enrollment
106
Prehension strength of the main hand will be assessed thanks to dynamometry, in order to evaluate patient's muscular strength
A 4 metres walking test will be performed to assess patient's walking speed
DXA measurement will be performed to assess patient's body composition
Patient's quality of life will be assessed thanks to the SARQOL questionnaire
Life habits Questionnaire
Service de Rhumatologie - Hôpital Edouard Herriot
Lyon, France
Muscular strength
Muscular strength is the first outcome to evaluate sarcopenia
Time frame: At day 1
Walking speed
Walking speed is a physical performance outcome, that is the second outcome to evaluate sarcopenia
Time frame: At day 1
Muscular mass
Muscular mass is the third outcome to evaluate sarcopenia and will be assessed using DXA
Time frame: Up to 4 month after inclusion
Alcohol consumption
Time frame: At day 1
Tobacco consumption
Time frame: At day 1
Time of sport practice per month
Number of hours of sport practice per month is the first outcome to evaluate patient's global physical activity.
Time frame: At day 1
Physical activity rate in work
Physical activity rate in work can be light, medium, high or not applicable if the patient does not work ; it is the second outcome to evaluate patient's physical global activity.
Time frame: At day 1
Average walking time in a week
Average walking time in a week is the third outcome to evaluate patient's physical global activity.
Time frame: At day 1
Score at the SARQOL questionnaire
Quality of life will be assessed thanks to the SARQOL questionnaire (score between 0 and 100)
Time frame: At day 1
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.